Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04007757 · ClinicalTrials.gov registry record

Recovery and Outcomes From Stroke

A clinical trial of Intracerebral Hemorrhage, sponsored by State University of New York at Buffalo.

Completed
Registry status
500
Enrollment target
8
Study locations

NCT04007757 is a study of Intracerebral Hemorrhage that has completed, run by State University of New York at Buffalo. The registered enrollment target is 500 participants, below the 1,159-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (57% lower). The trial reports 8 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04007757, a study of Intracerebral Hemorrhage, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
500 participants
Enrollment target
8
Study locations

Study Summary

The investigators will perform follow-up on 500 cases of deep and lobar intracerebral hemorrhage to perform advanced neuroimaging before 45 days post stroke, and evaluations of motor and cognitive function at baseline, 3 months and 6 months to determine predictors of recovery, progressive cognitive or functional impairment.

Conditions Studied

Study Locations (8)

Illinois

  • University of Illinois Chicago - Chicago

Kentucky

  • Baptist Health Louisville - Louisville

Maryland

  • University of Maryland - Baltimore

Massachusetts

  • Massachusetts General Hospital - Boston

New York

  • Columbia University - New York

North Carolina

  • Duke University - Durham

Ohio

  • University of Cincinnati - Cincinnati

Texas

  • Houston Methodist - Houston

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2017-08-23
Est. Completion 2024-10-31

What the Registry Record Tells You About NCT04007757

The ClinicalTrials.gov registry entry for NCT04007757 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,159-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (57% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 0 interventions.

NCT04007757 reports 8 study locations spanning 8 distinct geographic areas - top geographies include Illinois, Kentucky, Maryland.

Frequently Asked Questions

What is clinical trial NCT04007757 about?

NCT04007757 is a clinical study titled "Recovery and Outcomes From Stroke". The investigators will perform follow-up on 500 cases of deep and lobar intracerebral hemorrhage to perform advanced neuroimaging before 45 days post stroke, and evaluations of motor and cognitive function at baseline, 3 months and 6 months to determine predictors of recovery, progressive cognitive ...

What is the current status of trial NCT04007757?

This trial is currently completed. The enrollment target is 500 participants. The study started on 2017-08-23. Estimated completion is 2024-10-31.

What conditions does trial NCT04007757 study?

This clinical trial studies the following conditions: Intracerebral Hemorrhage.

Who is sponsoring clinical trial NCT04007757?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04007757 being conducted?

This trial has 8 study locations across Illinois, Kentucky, Maryland, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intracerebral Hemorrhage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.